valuation thoughts, page-190

Are you more a " that one looks pretty " kinda buyer rolling?
Without having some way of predicting what future value might be, how could anyone invest in a drug discovery biotech?

A valuation model. plus constant due diligence is required to not only find that diamond in rough, but to also work out when to hold em, and when to fold em and when to buy more of em.

Can I give you some examples?
IMU, started buying the at 1c, had had my fill when they got to 3.7c. Average price of 2.7c. My valuation model had a price target of 20c for their B cell tech. And this increased ss more tech was added. I started reducing my holding as it hit mid 50c. Am down to core holding of 1 million shares now.

VLA, started in at 25c with a valuation model target of $1. It was bouhht out for $1.65.

OPT, buying between 35c and 65c with valuation model target of $2. Sold at a bit over $3.

Do you need any more?